“a decreasing trend”

However, a decreasing trend for precipitation was observed (Linear regression, F = 7.82, df = 1, P = 0.003).

The age-standardized incidence and mortality rates of CRC in the under-50 group remained stable over the years, while a decreasing trend was clearly seen in the mortality rates of CRC in the above-50 group (p=0.003).

However, there was a decreasing trend over the five years in the mean household volume of SSBs purchased (–5·9 L; linear trend P -value = 0·030) and an increasing trend in the household volume of AFSBs purchased (+5·3 L from 2015 to 2019; linear trend P -value = 0·003) (Fig. 2 ).

In order to show the withdrawal effect of deep pressure after the treatment, we analyzed the trend between the two groups, and the remaining effect of deep pressure on skin conductance showed a decreasing trend compared to the baseline condition in group I ( p = 0.003), but there was no change or a stable trend in group II ( p = 0.773).

Briefly, VTI QRS-3D showed a decreasing trend across age groups from 18 to 65 years ( p = 0.003 for females, p < 0.0001 for males).

A decreasing trend was observed in all regions except West which showed an increase with AAPC of 0.38 (95% CI, 0.15 to 0.62, p=0.003).

A decreasing trend was observed for KC ( P =0.009) and an increasing trend for BK ( P =0.003) and FED ( P =0.001).

Average Triglyceride in the first, fourth and seventh phases were 128.57 ± 13.33, 101.43 ± 57.99 and 87.40 ± 57.59 mg/dl, respectively, which shows a decreasing trend (P = 0.003).

Tobramycin showed a decreasing trend; however, its combination with dexamethasone increased progressively both in prescription numbers and portions ( p = 0.003 and p < 0.001).

In contrast, there was a decreasing trend in pediatric BSIs (29.46% vs 25.85%, P = .0035, Fig. 2 d), which may be mainly ascribed to the sharp drop in the proportions of A. baumannii and S. aureus during the same periods.

A decreasing trend in the number of cases was noted during the analyzed period ( p = 0.004).

Unexpectedly, we observed a decreasing trend of within-group-averaged r 2 (i.e., six samples from 6 different threshold levels) as the motion threshold level became less stringent (Fig. 4 C; r = − 0.95, p = 0.004).

We confirmed a decreasing trend in both decades, with a yearly average decrease of 6.4% (IRR=0.939, 95% CI 0.899–0.980; p=0.004) in the first decade, and of 6.2% (IRR=0.920, 95% CI 0.849–0.997; p=0.043) in the second decade.

There was a decreasing trend in the reported values with time ( r = −0·5, P = 0·004), large estimates being more frequent at first.

The creatinine levels of the control group showed a decreasing trend depending on VEGF +936C>T ( p = 0.004, Table S8 ).

44.8, P <0.01) in the MetS group, and ANSI scores showed a decreasing trend ( P =0.004) as the number of MetS components increased.

Within the diabetic cohorts, glimepiride+bisoprolol alone had a decreasing trend (−0.66 percentage points from baseline to week 11; Wilcoxon p = 0.004) and was trending towards healthy levels.

The median surgical time showed a decreasing trend from 2011 to 2020 (τ = −0.012, P = 0.004).

Segmented regression showed an increasing trend in impact factor for publications during 1972 to 1996 ( β = 0.16, p = 0.004) and a decreasing trend during 1997 to 2023 ( β = −0.048, p = 0.005).

The prevalence of Pseudomonas aeruginosa showed a decreasing trend ( p = 0.004), whereas coagulase-negative Staphylococcus (CNS) and Propionibacterium species were increasingly detected ( p < 0.001).

The age, smoking, as well as the levels of BMI, AHI, ODI, MAT, TSA90 and the prevalence of hypertension and COPD exhibited a decreasing trend with the elevated MSpO 2 , except for the levels of LSpO 2 and the prevalence of dyslipidemia, which showed an increasing trend (all P < 0.005).

Nine out of the 14 FAs showed significant differences in the relative amounts between maturity stages, where an increasing trend was found for 14:0 ( F = 20.41, p < 0.05), 20:2 ( F = 4.17, p = 0.006), 20:3n3 ( F = 3.08, p = 0.024), 20:4n6 ( F = 4.48, p = 0.004) and 20:5n3 ( F = 3.20, p = 0.028), a decreasing trend for 18:0 ( F = 4.31, p = 0.005), 18:1n9 ( F = 3.53, p = 0.013) and 20:1 ( F = 18.37, p < 0.05), and an increase for 16:0 from stages III–VI ( F = 18.18, p < 0.05), followed by a decrease at stage VII (Fig. 4 a; Additional file 1 : Table S1).

The prevalence of methicillin resistance showed a decreasing trend ( P = 0.005) (See Supplementary Fig. 1, Additional File 1 ).

p16 INK4a expression showed a decreasing trend (Figure 3H ), correlating positively with CD27 − CD28 − cell proportion (Pearson r = 0.838, p = 0.005; Figure 3I ).

A decreasing trend in IS incidence was noted (Kendall τ = −0.689, p = 0.005), with the highest number of cases recorded in 2013 (10,033) and the lowest in 2020 (9006), while the use of IVT increased from 3.2% in 2011 to 18.3% in 2020 (Kendall τ = 0.956, p < 0.001).